Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2023-06-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2023-06-30 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report of Changes in Shareholding by Major Shareholders and Related Parties). This type of filing is specifically used to notify the market of changes in the ownership stakes of major shareholders, which falls under the category of Major Shareholding Notification (MRQ).
2023-06-30 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from Inbiogen regarding a 'Resolution for Convening a General Meeting of Shareholders' (주주총회소집결의). It specifically details a correction (정정신고) to the date of an Extraordinary General Meeting. Since this document relates to the formal process of calling a shareholder meeting and providing notice of agenda items (such as director appointments), it falls under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2023-06-15 Korean
불성실공시법인지정
Regulatory Filings Classification · 100% confidence The document is a formal notification from the Korea Exchange (KRX) regarding the designation of Inbiogen as an 'unfaithful disclosure corporation' (불성실공시법인). It details the type of violation, the penalty (fine), and the regulatory basis for the designation. Since this is a regulatory announcement regarding compliance and disclosure violations that does not fit into specific categories like M&A or financial reports, it falls under the general regulatory filing category.
2023-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is a mandatory disclosure for major shareholders (in this case, Bucket Studio) regarding changes in their shareholding or convertible bond holdings in a listed company (Inbiogen). This falls under the category of 'Director's Dealing' or 'Major Shareholding Notification' depending on the context, but given the specific nature of insider/major shareholder ownership reporting, it is classified as DIRS.
2023-06-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details changes in share ownership by a major shareholder (Bucket Studio) in the issuer (Inbiogen). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-06-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.